Back
Protagonist Therapeutics Vs. B. Riley Financial Industry Stock Comparison
Buy
57
PTGX
Protagonist Therapeutics
Last Price:
26.09
Seasonality Move:
28.29%
Sell
50
RILY
B. Riley Financial
Last Price:
31.11
Seasonality Move:
16.09%
Buy
57
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $26.09. The Score for PTGX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
B. Riley Financial (RILY)
is a Sell
Is B. Riley Financial a Buy, Sell or Hold?
- The current B. Riley Financial [RILY] share price is $31.10. The Score for RILY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- RILY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $26.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight selling pressure.
RILY Stock Price Chart
What is B. Riley Financial's stock price today?
-
The B. Riley Financial share price today is $31.10
The current trend is moderately bullish and RILY is experiencing slight selling pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.66 | Sell |
| Relative Strength Index (14 RSI): | 46.72 | Sell |
| Chaikin Money Flow: | -63474 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.39 - 27.87) | Sell |
| Bollinger Bands (100): | (23.44 - 29.1) | Sell |
RILY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.46 | Buy |
| Relative Strength Index (14 RSI): | 58.8 | Buy |
| Chaikin Money Flow: | -424818 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.04 - 31.78) | Buy |
| Bollinger Bands (100): | (17.39 - 25.99) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.42 | Buy |
| 20-day SMA: | 26.29 | Sell |
| 50-day SMA: | 28.09 | Sell |
| 200-day SMA: | 21.93 | Buy |
| 8-day EMA: | 25.68 | Buy |
| 20-day EMA: | 26.24 | Sell |
| 50-day EMA: | 26.79 | Sell |
| 200-day EMA: | 23.61 | Buy |
RILY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.96 | Sell |
| 20-day SMA: | 26.66 | Buy |
| 50-day SMA: | 22.6 | Buy |
| 200-day SMA: | 31.16 | Sell |
| 8-day EMA: | 31.86 | Sell |
| 20-day EMA: | 28.17 | Buy |
| 50-day EMA: | 24.54 | Buy |
| 200-day EMA: | 28.32 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.
B. Riley Financial Earnings Growth & RILY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Protagonist Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
B. Riley Financial Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||